Uncoupling the Oncogenic Engine.

Abstract excerpt

Inhibition of oncogenic signaling and correction of aberrant metabolic processes may be key paradigms to eliminate cancer cells. The high incidence of activating RAS mutations and hyperactivated ERK1/2 signaling observed in many human tumors and the lack of effective targeted therapies to elicit long-term inhibition of the RAS-ERK1/2 signaling pathway add to the importance of discovering novel strategies to treat...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Mitogen-Activated Protein Kinases
• Share to Models, Genetic
• Share to Mutation